Clinical evaluation of cephaloglycin in the treatment of urinary tract infections.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin; D001431:Bacteriological Techniques; D002214:Capsules; D002509:Cephaloridine; D002511:Cephalosporins / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use* / Q000652:urine; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004355:Drug Stability; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012871:Skin Diseases / Q000139:chemically induced; D012996:Solutions; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D002214:Capsules; D002511:Cephalosporins; D012996:Solutions; D000667:Ampicillin; D002509:Cephaloridine